| Product Code: ETC6736665 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Arthritis Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Arthritis Market Revenues & Volume, 2021 & 2031F |
3.3 China Arthritis Market - Industry Life Cycle |
3.4 China Arthritis Market - Porter's Five Forces |
3.5 China Arthritis Market Revenues & Volume Share, By Rheumatoid Drug Type, 2021 & 2031F |
3.6 China Arthritis Market Revenues & Volume Share, By Rheumatoid Treatment, 2021 & 2031F |
3.7 China Arthritis Market Revenues & Volume Share, By Rheumatoid Diagnosis, 2021 & 2031F |
3.8 China Arthritis Market Revenues & Volume Share, By Osteoarthritis Type, 2021 & 2031F |
3.9 China Arthritis Market Revenues & Volume Share, By Osteoarthritis Diagnosis, 2021 & 2031F |
3.10 China Arthritis Market Revenues & Volume Share, By Osteoarthritis Treatment, 2021 & 2031F |
3.11 China Arthritis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 China Arthritis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in China leading to a higher prevalence of arthritis |
4.2.2 Growing awareness about arthritis and its management among the Chinese population |
4.2.3 Rising disposable income leading to higher spending on arthritis treatment and management |
4.3 Market Restraints |
4.3.1 Limited access to quality healthcare services in certain regions of China |
4.3.2 High cost of arthritis medications and treatments impacting affordability for some segments of the population |
4.3.3 Lack of standardized guidelines for arthritis management leading to variability in treatment outcomes |
5 China Arthritis Market Trends |
6 China Arthritis Market, By Types |
6.1 China Arthritis Market, By Rheumatoid Drug Type |
6.1.1 Overview and Analysis |
6.1.2 China Arthritis Market Revenues & Volume, By Rheumatoid Drug Type, 2021- 2031F |
6.1.3 China Arthritis Market Revenues & Volume, By Biologics, 2021- 2031F |
6.1.4 China Arthritis Market Revenues & Volume, By Non-Biologics, 2021- 2031F |
6.1.5 China Arthritis Market Revenues & Volume, By Steroids, 2021- 2031F |
6.1.6 China Arthritis Market Revenues & Volume, By Analgesics, 2021- 2031F |
6.1.7 China Arthritis Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.1.8 China Arthritis Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Arthritis Market, By Rheumatoid Treatment |
6.2.1 Overview and Analysis |
6.2.2 China Arthritis Market Revenues & Volume, By Synovectomy, 2021- 2031F |
6.2.3 China Arthritis Market Revenues & Volume, By Tendon Repair, 2021- 2031F |
6.2.4 China Arthritis Market Revenues & Volume, By Joint Fusion, 2021- 2031F |
6.2.5 China Arthritis Market Revenues & Volume, By Symptomatic Treatment, 2021- 2031F |
6.2.6 China Arthritis Market Revenues & Volume, By Intermediate Corticosteroid Therapies, 2021- 2031F |
6.2.7 China Arthritis Market Revenues & Volume, By DMARD Therapies, 2021- 2031F |
6.3 China Arthritis Market, By Rheumatoid Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 China Arthritis Market Revenues & Volume, By C.R.P. Test, 2021- 2031F |
6.3.3 China Arthritis Market Revenues & Volume, By C.C.P., 2021- 2031F |
6.3.4 China Arthritis Market Revenues & Volume, By E.S.R. Test, 2021- 2031F |
6.4 China Arthritis Market, By Osteoarthritis Type |
6.4.1 Overview and Analysis |
6.4.2 China Arthritis Market Revenues & Volume, By Hip, 2021- 2031F |
6.4.3 China Arthritis Market Revenues & Volume, By Spinal, 2021- 2031F |
6.4.4 China Arthritis Market Revenues & Volume, By Knee, 2021- 2031F |
6.4.5 China Arthritis Market Revenues & Volume, By Foot and Ankle, 2021- 2031F |
6.4.6 China Arthritis Market Revenues & Volume, By Shoulder, 2021- 2031F |
6.4.7 China Arthritis Market Revenues & Volume, By Hand, 2021- 2031F |
6.5 China Arthritis Market, By Osteoarthritis Diagnosis |
6.5.1 Overview and Analysis |
6.5.2 China Arthritis Market Revenues & Volume, By Imaging, 2021- 2031F |
6.5.3 China Arthritis Market Revenues & Volume, By Joint Fluid Analysis, 2021- 2031F |
6.5.4 China Arthritis Market Revenues & Volume, By Others, 2021- 2031F |
6.6 China Arthritis Market, By Osteoarthritis Treatment |
6.6.1 Overview and Analysis |
6.6.2 China Arthritis Market Revenues & Volume, By Medication, 2021- 2031F |
6.6.3 China Arthritis Market Revenues & Volume, By Drugs, 2021- 2031F |
6.6.4 China Arthritis Market Revenues & Volume, By Assistive Devices, 2021- 2031F |
6.6.5 China Arthritis Market Revenues & Volume, By Surgery, 2021- 2031F |
6.6.6 China Arthritis Market Revenues & Volume, By Therapy, 2021- 2031F |
6.7 China Arthritis Market, By Route of Administration |
6.7.1 Overview and Analysis |
6.7.2 China Arthritis Market Revenues & Volume, By Oral, 2021- 2031F |
6.7.3 China Arthritis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.8 China Arthritis Market, By End-Users |
6.8.1 Overview and Analysis |
6.8.2 China Arthritis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.8.3 China Arthritis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.8.4 China Arthritis Market Revenues & Volume, By Medical Institutes, 2021- 2031F |
6.8.5 China Arthritis Market Revenues & Volume, By Medical Institutes, 2021- 2031F |
6.8.6 China Arthritis Market Revenues & Volume, By Research Organizations, 2021- 2031F |
6.8.7 China Arthritis Market Revenues & Volume, By Others, 2021- 2031F |
7 China Arthritis Market Import-Export Trade Statistics |
7.1 China Arthritis Market Export to Major Countries |
7.2 China Arthritis Market Imports from Major Countries |
8 China Arthritis Market Key Performance Indicators |
8.1 Average waiting time for arthritis diagnosis and treatment |
8.2 Percentage of healthcare facilities offering specialized arthritis care |
8.3 Number of research studies and clinical trials focused on arthritis treatment and management |
9 China Arthritis Market - Opportunity Assessment |
9.1 China Arthritis Market Opportunity Assessment, By Rheumatoid Drug Type, 2021 & 2031F |
9.2 China Arthritis Market Opportunity Assessment, By Rheumatoid Treatment, 2021 & 2031F |
9.3 China Arthritis Market Opportunity Assessment, By Rheumatoid Diagnosis, 2021 & 2031F |
9.4 China Arthritis Market Opportunity Assessment, By Osteoarthritis Type, 2021 & 2031F |
9.5 China Arthritis Market Opportunity Assessment, By Osteoarthritis Diagnosis, 2021 & 2031F |
9.6 China Arthritis Market Opportunity Assessment, By Osteoarthritis Treatment, 2021 & 2031F |
9.7 China Arthritis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 China Arthritis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 China Arthritis Market - Competitive Landscape |
10.1 China Arthritis Market Revenue Share, By Companies, 2024 |
10.2 China Arthritis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here